About
Read more on www.warnerchilcott.com.
Warner Chilcott's Forward Looking Statements:
This press release contains forward-looking statements, including statements concerning our operations, our anticipated economic performance and financial condition, and our business plans and growth strategy and product development efforts. These statements constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The words 'may,' 'might,' 'will,' 'should,' 'estimate,' 'project,' 'plan,' 'anticipate,' 'expect,' intend,' 'outlook,' 'believe' and other similar expressions are intended to identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. These forward-looking statements are based on estimates and assumptions by our management that, although we believe to be reasonable, are inherently uncertain and subject to a number of risks and uncertainties.
The following represent some, but not necessarily all, of the
factors that could cause actual results to differ from historical
results or those anticipated or predicted by our forward-looking
statements: our substantial indebtedness; competitive factors in the
industry in which we operate (including the approval and introduction
of generic or branded products that compete with our products); our
ability to protect our intellectual property; a delay in qualifying our
manufacturing facility to produce our products or production or
regulatory problems with either third party manufacturers upon whom we
may rely for some of our products or our own manufacturing facilities;
pricing pressures from reimbursement policies of private managed care
organizations and other third party payors, government sponsored health
systems, the continued consolidation of the distribution network
through which we sell our products, including wholesale drug
distributors and the growth of large retail drug store chains; the loss
of key senior management or scientific staff; adverse outcomes in our
outstanding litigation or an increase in the number of litigation
matters to which we are subject; government regulation affecting the
development, manufacture, marketing and sale of pharmaceutical
products, including our ability and the ability of companies with whom
we do business to obtain necessary regulatory approvals; our ability to
manage the growth of our business by successfully identifying,
developing, acquiring or licensing new products at favorable prices and
marketing such new products; our ability to obtain regulatory approval
and customer acceptance of new products, and continued customer
acceptance of our existing products; changes in tax laws or
interpretations that could increase our consolidated tax liabilities;
the other risks identified in our Annual Report on Form 10-K for the
year ended
We caution you that the foregoing list of important factors is not exclusive. In addition, in light of these risks and uncertainties, the matters referred to in our forward-looking statements may not occur. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as may be required by law.
SOURCE Warner Chilcott Limited